✦ LIBER ✦

The use of mifepristone in the treatment of neuropsychiatric disorders

✍ Scribed by Charles DeBattista; Joseph Belanoff

Book ID: 116908988
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 102 KB
Volume: 17
Category: Article
ISSN: 1043-2760
DOI: 10.1016/j.tem.2006.02.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Erratum: The use of mifepristone in the

Erratum: The use of mifepristone in the treatment of neuropsychiatric disorders: Trends in Endocrinology & Metabolism 17 (2006) 3, 117–121

📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 62 KB

The use of newer anticonvulsants in neur

The use of newer anticonvulsants in neuropsychiatric disorders

✍ Edward Kim 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 467 KB

The use of mifepristone in the treatment

The use of mifepristone in the treatment of Cushing's syndrome

✍ Carroll, T., (author);Findling, J., (author) 📂 Article 📅 2012 🏛 Portico 🌐 English ⚖ 996 KB

Genetic polymorphisms in the expression

Genetic polymorphisms in the expression and treatment of neuropsychiatric disorders

✍ Thomas W. McAllister; Lanier Summerall 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 511 KB

Novel physical treatments for the manage

Novel physical treatments for the management of neuropsychiatric disorders

✍ Gin S Malhi; Perminder Sachdev 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 196 KB

Homocysteine in neuropsychiatric disorde

Homocysteine in neuropsychiatric disorders of the elderly

✍ Sharon Reutens; Perminder Sachdev 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

## Abstract ## Objective There is increasing interest in homocysteine as a risk factor for neuropsychiatric disorders such as stroke, dementia, depression and Parkinson's disease. This article reviews the current literature on the relationship between homocysteine and these disorders to ascertain